InMed Pharmaceuticals Inc Working Capital to Net Assets Ratio

Latest as of June 2026: 67.1%

InMed Pharmaceuticals Inc working capital to net assets ratio. InMed Pharmaceuticals Inc (INM) has a Working Capital to Net Assets ratio of 67.1% as of June 2026. Working capital of $721.65 Million (current assets of $2.68 Billion minus current liabilities of $1.96 Billion) is measured against net assets of $1.08 Billion. A higher ratio indicates strong short-term liquidity financed by the equity base. Check how tangible is InMed Pharmaceuticals Inc's equity to evaluate the tangible quality of the company's equity base.

WC/NA Ratio

67.1%
Working Capital / Net Assets

Working Capital

$721.65 Million
USD

Current Assets

$2.68 Billion
USD

Current Liabilities

$1.96 Billion
USD

Working Capital to Net Assets Ratio of InMed Pharmaceuticals Inc (2001–2026)

Working capital to net assets ratio of InMed Pharmaceuticals Inc from 2001 to 2026. This chart shows how InMed Pharmaceuticals Inc's Working Capital to Net Assets ratio has evolved across 26 annual periods from 2001 to 2026. As of June 2026, the ratio stands at 67.1%, reflecting working capital of $721.65 Million against net assets of $1.08 Billion USD. See how many days can InMed Pharmaceuticals Inc fund operations to measure how many days the company can operate on defensive assets alone.

InMed Pharmaceuticals Inc Working Capital to Net Assets Ratio by Year (2001–2026)

InMed Pharmaceuticals Inc working capital to net assets ratio by year from 2001 to 2026. The table below presents the year-by-year Working Capital to Net Assets ratio for InMed Pharmaceuticals Inc from 2001 to 2026, covering 26 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For the complete balance sheet picture, see InMed Pharmaceuticals Inc asset portfolio.

Year WC/NA Ratio Working Capital (USD) Net Assets Current Assets Current Liabilities Change (pp)
2026 67.1% $721.65 Million $1.08 Billion $2.68 Billion $1.96 Billion ▼ -15.0 pp
2025 82.1% $15.02 Million $18.30 Million $17.53 Million $2.51 Million ▲ +9.1 pp
2024 73.0% $9.19 Million $12.59 Million $11.88 Million $2.70 Million ▼ -4.2 pp
2023 77.2% $12.36 Million $16.02 Million $15.01 Million $2.65 Million ▲ +8.0 pp
2022 69.2% $8.08 Million $11.69 Million $12.36 Million $4.27 Million ▼ -14.4 pp
2021 83.5% $7.62 Million $9.12 Million $10.36 Million $2.74 Million ▲ +4.7 pp
2020 78.9% $4.64 Million $5.88 Million $6.31 Million $1.68 Million ▼ -14.3 pp
2019 93.2% $12.94 Million $13.88 Million $14.13 Million $1.19 Million ▼ -1.9 pp
2018 95.1% $19.61 Million $20.62 Million $20.33 Million $713.02K ▲ +12.6 pp
2017 82.5% $5.06 Million $6.13 Million $5.34 Million $284.24K ▲ +120.5 pp
2016 -37.9% $-311.12K $820.48K $145.05K $456.17K ▼ -48.9 pp
2015 10.9% $139.53K $1.28 Million $202.04K $62.51K ▲ +3.3 pp
2014 7.6% $115.61K $1.52 Million $185.71K $70.11K ▼ -92.4 pp
2013 100.0% $-44.11K $-44.11K $5.09K $49.20K ▲ +0.0 pp
2012 100.0% $2.72K $2.72K $47.31K $44.59K ▲ +0.0 pp
2011 100.0% $202.29K $202.29K $248.50K $46.20K ▼ -10.9 pp
2010 110.9% $-1.33 Million $-1.20 Million $13.66K $1.35 Million ▲ +10.6 pp
2009 100.3% $-1.03 Million $-1.03 Million $22.52K $1.05 Million ▼ -552.9 pp
2008 653.2% $-907.83K $-138.98K $588.33K $1.50 Million ▲ +553.0 pp
2007 100.2% $-952.14K $-950.42K $361.68K $1.31 Million ▼ -31.6 pp
2006 131.8% $-639.85K $-485.38K $458.63K $1.10 Million ▼ -6.5 pp
2005 138.3% $-927.80K $-670.63K $626.16K $1.55 Million ▼ -75.6 pp
2004 213.9% $-503.93K $-235.55K $251.39K $755.33K ▲ +236.5 pp
2003 -22.6% $-54.57K $241.85K $414.47K $469.04K ▼ -95.9 pp
2002 73.3% $944.80K $1.29 Million $1.02 Million $74.45K ▲ +28.4 pp
2001 44.9% $1.88 Million $4.18 Million $2.37 Million $493.02K —
pp = percentage points